Bianca M. Liederer, Ph.D.
Affiliations: | 2005 | University of Kansas, Lawrence, KS, United States |
Area:
Pharmaceutical Chemistry, PharmacyGoogle:
"Bianca Liederer"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ronald T. Borchardt | grad student | 2005 | University of Kansas | |
| (Prodrug strategies for improving oral and blood -brain barrier delivery of opioid peptides.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chan P, Ding HT, Liederer BM, et al. (2021) Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor. Clinical and Translational Science |
| Hamilton GL, Chen H, Deshmukh G, et al. (2019) Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group. Bioorganic & Medicinal Chemistry Letters |
| Liederer BM, Cheong J, Chou KJ, et al. (2018) Preclinical Assessment of the ADME, Efficacy and Drug-Drug Interaction Potential of a Novel NAMPT Inhibitor. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-56 |
| Daemen A, Liu B, Song K, et al. (2018) Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State. Cell Metabolism |
| Durk MR, Deshmukh G, Valle N, et al. (2018) Use of Subcutaneous and Intraperitoneal Administration Methods to Facilitate Cassette Dosing in Microdialysis Studies in Rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals |
| Liang J, Labadie S, Zhang B, et al. (2017) From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors. Bioorganic & Medicinal Chemistry Letters |
| Wong H, Bohnert T, Damian-Iordache V, et al. (2017) Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective. Drug Discovery Today |
| Misner DL, Kauss MA, Singh J, et al. (2016) Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines. Cardiovascular Toxicology |
| Zak M, Yuen PW, Liu X, et al. (2016) Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors. Journal of Medicinal Chemistry |
| Liang J, Zhang B, Labadie S, et al. (2016) Lead optimization of a pyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies. Bioorganic & Medicinal Chemistry Letters |